Search

Diabetes and Its Complications: Therapies Available, Anticipated and Aspired

Journal: Current Diabetes Reviews
Volume: 17 Issue: 4 Year: 2021 Page: 397-420
Author(s): Anu Grover,Komal Sharma,Suresh Gautam,Srishti Gautam,Monica Gulati,Sachin Kumar Singh

Dopamine: The Forgotten Felon in Type 2 Diabetes

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5 Issue: 1 Year: 2011 Page: 61-65
Author(s): Sanjay Kalra, Bharti Kalra, Navneet Agrawal, Satish Kumar

Pathophysiology of Type 2 Diabetes: A General Overview of Glucose and Insulin Homeostasis

Ebook: The Role of Nitric Oxide in Type 2 Diabetes
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815079814122010004

Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications

Journal: Current Vascular Pharmacology
Volume: 17 Issue: 2 Year: 2019 Page: 153-163
Author(s): Muhammad A. Abdul-Ghani,Amin Jayyousi,Ralph A. DeFronzo,Nidal Asaad,Jassim Al-Suwaidi

Diabesity: Obesity And Type II Diabetes As A Real Health Problem In Developed Countries

Ebook: Diabesity: A Multidisciplinary Approach
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039801122010003

SGLT-2 Inhibitors: An Evidence-Based Perspective

Ebook: Frontiers in Clinical Drug Research-Diabetes and Obesity
Volume: 5 Year: 2020
Author(s): Siddhartha Dutta,Pramod Kumar Sharma,Arup Kumar Misra
Doi: 10.2174/9781681087535120050007

Sodium–Glucose Co-Transporters Inhibitors for Type 2 Diabetes Mellitus: The ‘New Kids on the Block’ in the Era of Evidence-based Medicine

Ebook: Frontiers in Clinical Drug Research-Diabetes and Obesity
Volume: 4 Year: 2019
Author(s): Cheow Peng Ooi,Norlaila Mustafa,Nor Azmi Kamaruddin,Munn Sann Lye
Doi: 10.2174/9781681084459119040005

Journal: Current Drug Targets
Volume: 14 Issue: 1 Year: 2013 Page: 1110-1117
Author(s): Chiranjib Chakraborty, George Priya Doss. C, Sanghamitra Bandyopadhyay

Therapeutic Management of Type 2 Diabetes: The Nitric Oxide Axis

Ebook: The Role of Nitric Oxide in Type 2 Diabetes
Volume: 1 Year: 2022
Author(s): Jennifer L. O’Connor
Doi: 10.2174/9789815079814122010013

Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials

Journal: Current Diabetes Reviews
Volume: 13 Issue: 4 Year: 2017 Page: 405-423
Author(s): Matthew J. Levine